Preparing for the Inevitable: Early Comprehensive Genomic Profiling for Patients With Localized Pancreatic Ductal Adenocarcinoma
A uniform strategy for ensuring patients with resected PDAC receive CGP may improve access to clinical trials and molecularly tailored treatment.
Authors
- John H. Strickler (ORCID: https://orcid.org/0000-0001-7579-1175)
- Daniel P. Nussbaum (ORCID: https://orcid.org/0000-0003-3070-6605)
- Emily Bolch
- Peter J. Allen (ORCID: https://orcid.org/0000-0001-7912-9197)
- Matthew Bao
- Ryne C. Ramaker (ORCID: https://orcid.org/0000-0001-8666-4841)
- Ethan Agritelley (ORCID: https://orcid.org/0009-0009-2728-0552)
Institutions
- Duke University (US)
- Duke Medical Center (US)
- Duke Cancer Institute
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1200/op-25-00548
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05